New expert guidance to help clinicians manage the treatment of patients with epilepsy during pregnancy has been released. Issued by the American Academy of Neurology, the […]

The full results of the ANNEXA-I trial have continued to show mixed effects of the factor Xa inhibitor reversal agent, andexanet (Andexxa/Ondexxya, AstraZeneca), in patients with […]

Meningitis has been highlighted as a novel risk factor for trigeminal neuralgia (TN) in a nationwide, propensity-matched study of hospital admissions. In multivariate analysis, the odds […]

CHICAGO — The diabetes/weight loss drug semaglutide is associated with a significantly greater risk for repeat operations in patients with diabetes who require lumbar surgery, a […]

CHICAGO — Early results from a first-in-human trial some 20 years in the making suggest that neural stem cell transplantation is safe and improves motor function […]

There is no association between the SARS-CoV-2 vaccine and the risk for new-onset seizure, data from a new meta-analysis of six randomized, placebo-controlled clinical trials (RCTs) […]

New guidelines to manage peripheral neuropathy related to Sjogren disease have been developed by a multidisciplinary team of physicians from across medicine. The guidelines will provide […]

Having two copies of the APOE4 gene may be the genetic cause of up to one fifth of all Alzheimer’s disease (AD) cases, a new study […]

Proton pump inhibitors (PPIs), which are used to control acid reflux, are associated with an increased risk for migraine and other severe headache types, new research […]